Şunu aradınız:: integrase (Danca - İngilizce)

anti-integrase
integrase inhibitor

integrase-hæmmer
integrase inhibitor

integrase strengoverførsels-hæmmere
integrase strand transfer inhibitors

integrase strand transfer-hæmmer
integrase strand transfer inhibitor

virus producerer et enzym, der hedder hiv-integrase.
the virus produces an enzyme called hiv integrase.

hiv-virus producerer et enzym kaldet hiv-integrase.
the hiv virus produces an enzyme called hiv integrase.

hiv-1-integrase-hæmmer (f.eks. raltegravir);
hiv-1 integrase inhibitor (e.g. raltegravir);

det blokerer et enzym kaldet integrase, der medvirker ved formeringen af hiv.
it blocks an enzyme called integrase, which is involved in a step in the reproduction of hiv.

hvordan isentress virker virus producerer et enzym, der hedder hiv- integrase.
how isentress works the virus produces an enzyme called hiv integrase.

det blokerer et enzym kaldet integrase, som indgår i et trin i hiv- virussets formering.
it blocks an enzyme called integrase, which is involved in a step in the reproduction of hiv.

hæmning af integrase hindrer den kovalente insertion, eller integration, af hiv-genomet i værtscellegenomet.
inhibition of integrase prevents the covalent insertion, or integration, of the hiv genome into the host cell genome.

det blokerer et enzym (integrase) , der indgår i et trin i hiv-virussets formering.
it blocks an enzyme (integrase) that is involved in a step in the reproduction of hiv.

raltegravir hæmmer den katalytiske aktivitet af integrase, som er et hiv-kodet enzym, der er nødvendig for viral replikation.
raltegravir inhibits the catalytic activity of integrase, an hiv-encoded enzyme that is required for viral replication.

elvitegravirresistente vira viste forskellige grader af krydsresistens over for integrase strand transfer- hæmmeren raltegravir, afhængigt af substitutionernes type og antal.
elvitegravir-resistant viruses show varying degrees of cross-resistance to the integrase strand transfer inhibitor raltegravir depending on the type and number of substitutions.

alle hiv 1-isolater fra patienter i begge behandlingsgrupper, der udviklede resistensmutationer over for elvitegravir i integrase, udviklede også resistensmutationer over for emtricitabin i rt.
all hiv-1 isolates from patients in both treatment groups who developed resistance mutations to elvitegravir in integrase also developed resistance mutations to emtricitabine in rt.

andre substitutioner i integrase, der opstod i tillæg til primær insti- resistenssubstitution i enkelte tilfælde, var h51y, l68v, g140c, s153a, e157q og g163r.
other substitutions in integrase that occurred in addition to a primary insti resistance substitution each in single cases were h51y, l68v, g140c, s153a, e157q, and g163r.

blandt disse 10 hiv 1-isolater var de mutationer, der opstod, m184v/i (n = 9) og k65r/n (n = 2) i rt og t66t/a/i/v (n = 2), e92q (n = 4), q148q/r (n = 1) og n155h (n = 2) i integrase.
among these 10 hiv-1 isolates, the mutations that emerged were m184v/i (n = 9) and k65r/n (n = 2) in rt and t66t/a/i/v (n = 2), e92q (n = 4), q148q/r (n = 1), and n155h (n = 2) in integrase.